{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:01:25Z","timestamp":1783486885491,"version":"3.55.0"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Renal cell carcinoma (RCC) represents one of the most resistant tumors to radiation and chemotherapy. Current therapies for RCC patients are inefficient due to the lack of diagnostic and therapeutic markers. Our recent studies have suggested an association of sperm-associated antigen 9 (SPAG9) with ovarian carcinomas. In the present study, we investigated the clinical relevance of SPAG9 in RCC patients. RT-PCR analysis showed expression of SPAG9 transcript in RCC tissues and RCC cell lines. In situ RNA hybridization and immunohistochemistry analyses confirmed the expression of SPAG9 in 88% of cancer patients, suggesting that SPAG9 participates in renal cancer. In addition, immunoblotting and ELISA analyses revealed a humoral immune response against SPAG9 in the sera of RCC patients but not in healthy individuals. Consistent with the clinical findings, knockdown of SPAG9 expression in RCC cells with specific siRNA significantly reduced cell growth and colony formation. Using in vitro wound healing and Matrigel invasion assays, we found that cell migration and invasive ability were also significantly inhibited. Furthermore, in vivo xenograft studies in nude mice revealed that administration of a SPAG9 siRNA plasmid significantly inhibited tumor growth. In conclusion, SPAG9 expression is associated with clinicopathologic features of tumors, suggesting that SPAG9 could contribute to the early spread of cancer. These results indicate that SPAG9 may have a role in tumor development and metastasis and thus could serve as a novel target for early detection and treatment of RCC. [Cancer Res 2008;68(20):8240\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-1708","type":"journal-article","created":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T10:52:27Z","timestamp":1224067947000},"page":"8240-8248","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Sperm-Associated Antigen 9 Is Associated With Tumor Growth, Migration, and Invasion in Renal Cell Carcinoma"],"prefix":"10.1158","volume":"68","author":[{"given":"Manoj","family":"Garg","sequence":"first","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Kanojia","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aashima","family":"Khosla","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namrata","family":"Dudha","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Sati","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipak","family":"Chaurasiya","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmala","family":"Jagadish","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amlesh","family":"Seth","sequence":"additional","affiliation":[{"name":"2Department of Urology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajive","family":"Kumar","sequence":"additional","affiliation":[{"name":"3Institute of Rotary Cancer Hospital, All India Institute of Medical Sciences,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samir","family":"Gupta","sequence":"additional","affiliation":[{"name":"4Oncology Center, Research and Referral, Army Hospital, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Gupta","sequence":"additional","affiliation":[{"name":"5Moolchand Hospital, New Delhi, India; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal Kumar","family":"Lohiya","sequence":"additional","affiliation":[{"name":"6Reproductive Physiology Section, Department of Zoology, University of Rajasthan, Jaipur, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Suri","sequence":"additional","affiliation":[{"name":"1Cancer Microarray, Genes and Proteins Laboratory, National Institute of Immunology,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"2022061700271503200_B1","doi-asserted-by":"crossref","unstructured":"Vogelzang NJ, Stadler WM. Kidney cancer. Lancet\u20081998; 352: 1691\u20136.","DOI":"10.1016\/S0140-6736(98)01041-1"},{"key":"2022061700271503200_B2","doi-asserted-by":"crossref","unstructured":"Motzer RJ, Russo P. Systemic therapy for renal cell carcinoma. J Urol\u20082000; 163: 408\u201317.","DOI":"10.1016\/S0022-5347(05)67889-5"},{"key":"2022061700271503200_B3","doi-asserted-by":"crossref","unstructured":"Togashi A, Katagiri T, Ashida S, et al. Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma and potential target for molecular therapy. Cancer Res\u20082005; 11: 4817\u201326.","DOI":"10.1158\/0008-5472.CAN-05-0120"},{"key":"2022061700271503200_B4","doi-asserted-by":"crossref","unstructured":"Suri A. Cancer testis antigens-their importance in immunotherapy and in the early detection of cancer. Expert Opin Biol Ther\u20082006; 6: 379\u201389.","DOI":"10.1517\/14712598.6.4.379"},{"key":"2022061700271503200_B5","unstructured":"Scanlan MJ, Andrew JG, Simpson GJA, Old LJ. The cancer\/testis genes: Review, standardization, and commentary. Cancer Immun\u20082004; 4: 1."},{"key":"2022061700271503200_B6","doi-asserted-by":"crossref","unstructured":"Simpson AJ, Caballero OL, Jungbluth A, Chen YT, Old LJ. Cancer\/testis antigens, gametogenesis and cancer. Nat Rev Cancer\u20082005; 5: 615\u201325.","DOI":"10.1038\/nrc1669"},{"key":"2022061700271503200_B7","doi-asserted-by":"crossref","unstructured":"Zendman AJ, Ruiter DJ, Van Muijen GN. Cancer\/testis-associated genes: Identification, expression profile, and putative function. J Cell Physiol\u20082003; 194: 272\u201388.","DOI":"10.1002\/jcp.10215"},{"key":"2022061700271503200_B8","doi-asserted-by":"crossref","unstructured":"Garg M, Chaurasiya D, Rana R, et al. Sperm-associated antigen 9, a novel cancer testis antigen, is a potential target for immunotherapy in epithelial ovarian cancer. Clin Cancer Res\u20082007; 13: 1421\u20138.","DOI":"10.1158\/1078-0432.CCR-06-2340"},{"key":"2022061700271503200_B9","doi-asserted-by":"crossref","unstructured":"Shankar S, Mohapatra B, Suri A. Cloning of a novel human testis mRNA specifically expressed in testicular haploid germ cells, having unique palindromic sequences and encoding a leucine zipper dimerization motif. Biochem Biophys Res Commun\u20081998; 243: 561\u20135.","DOI":"10.1006\/bbrc.1997.7943"},{"key":"2022061700271503200_B10","doi-asserted-by":"crossref","unstructured":"Jagadish N, Rana R, Selvi R, et al. Characterization of a novel human sperm-associated antigen 9 (SPAG9) having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem J\u20082005; 389: 73\u201382.","DOI":"10.1042\/BJ20041577"},{"key":"2022061700271503200_B11","doi-asserted-by":"crossref","unstructured":"Qi M, Elion EA. MAP kinase pathways. J Cell Sci\u20082005; 118: 3569\u201372.","DOI":"10.1242\/jcs.02470"},{"key":"2022061700271503200_B12","doi-asserted-by":"crossref","unstructured":"Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP. Scaffold proteins of MAP-kinase modules. Oncogene\u20082007; 26: 3185\u2013202.","DOI":"10.1038\/sj.onc.1210411"},{"key":"2022061700271503200_B13","doi-asserted-by":"crossref","unstructured":"Lee CL, Onesime D, Reddy CD, Dhanasekaran N, Reddy EP. JLP: A scaffolding protein that tethers JNK\/p38 MAPK signaling modules and transcription factors. Proc Natl Acad Sci U S A\u20082002; 99: 14189\u201394.","DOI":"10.1073\/pnas.232310199"},{"key":"2022061700271503200_B14","doi-asserted-by":"crossref","unstructured":"Kelkar N, Standen CL, Davis RJ. Role of the JIP4 scaffold protein in the regulation of mitogen-activated protein kinase signaling pathways. Mol Cell Biol\u20082005; 25: 2733\u201343.","DOI":"10.1128\/MCB.25.7.2733-2743.2005"},{"key":"2022061700271503200_B15","doi-asserted-by":"crossref","unstructured":"Kashef K, Xu H, Reddy P, Dhanasekaran DN. Endodermal differentiation of murine embryonic carcinoma cells by retinoic acid requires JLP, a JNK-scaffolding protein. J Cell Biochem\u20082006; 98: 715\u201322.","DOI":"10.1002\/jcb.20930"},{"key":"2022061700271503200_B16","doi-asserted-by":"crossref","unstructured":"Willis S, Hutchins AM, Hammet F, et al. Detailed gene copy number and RNA expression analysis of the 17q12\u201323 region in primary breast cancers. Genes Chromosomes Cancer\u20082003; 36: 382\u201392.","DOI":"10.1002\/gcc.10138"},{"key":"2022061700271503200_B17","doi-asserted-by":"crossref","unstructured":"Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y. Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia\u20082002; 4: 295\u2013303.","DOI":"10.1038\/sj.neo.7900251"},{"key":"2022061700271503200_B18","doi-asserted-by":"crossref","unstructured":"Linn SC, West RB, Pollack JR, et al. Gene expression patterns and gene copy number changes in dermatofibrosarcoma protuberans. Am J Pathol\u20082003; 163: 2383\u201395.","DOI":"10.1016\/S0002-9440(10)63593-6"},{"key":"2022061700271503200_B19","doi-asserted-by":"crossref","unstructured":"Helm J, Enkemann SA, Coppola D, Barthel JS, Kelley ST, Yeatman TJ. Dedifferentiation precedes invasion in the progression from Barrett's metaplasia to esophageal adenocarcinoma. Clin Cancer Res\u20082005; 11: 2478\u201385.","DOI":"10.1158\/1078-0432.CCR-04-1280"},{"key":"2022061700271503200_B20","doi-asserted-by":"crossref","unstructured":"Rana R, Jagadish N, Garg M, et al. Small interference RNA-mediated knockdown of sperm associated antigen 9 having structural homology with c-Jun N-terminal kinase-interacting protein. Biochem Biophys Res Commun\u20082006; 340: 158\u201364.","DOI":"10.1016\/j.bbrc.2005.11.168"},{"key":"2022061700271503200_B21","doi-asserted-by":"crossref","unstructured":"Higgins JP, Shinghal R, H Gill, et al. Gene expression patterns in renal cell carcinoma assessed by complementary DNA microarray. Am J Pathol\u20082003; 162: 925\u201332.","DOI":"10.1016\/S0002-9440(10)63887-4"},{"key":"2022061700271503200_B22","doi-asserted-by":"crossref","unstructured":"Lam JS, Pantuck AJ, Belldegrun AS, Figlin RA. Protein expression profiles in renal cell carcinoma: staging, prognosis, and patient selection for clinical trials. Clin Cancer Res\u20082007; 13: 703\u20138s.","DOI":"10.1158\/1078-0432.CCR-06-1864"},{"key":"2022061700271503200_B23","doi-asserted-by":"crossref","unstructured":"Price JT, Bonovich MT, Kohn EC. The biochemistry of cancer dissemination. Crit Rev Biochem Mol Biol\u20081997; 32: 175\u2013253.","DOI":"10.3109\/10409239709082573"},{"key":"2022061700271503200_B24","unstructured":"Neumann E, Engelsberg A, Decker J, et al. Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and Glycoprotein 75 in human RCC: candidates for T-Cell-based immunotherapies. Cancer Res\u20081998; 58: 4090\u20135."},{"key":"2022061700271503200_B25","doi-asserted-by":"crossref","unstructured":"Yamanaka K, Miyake H, Hara I, et al. Expression of MAGE genes in renal cell carcinoma. Int J Mol Med\u20081998; 2: 57\u201360.","DOI":"10.3892\/ijmm.2.1.57"},{"key":"2022061700271503200_B26","doi-asserted-by":"crossref","unstructured":"Rana R, Jagadish N, Garg M, et al. Immunogenicity study of recombinant human sperm associated antigen 9 (SPAG9) in bonnet macaque (Macaca radiata). Hum Reprod\u20082006; 21: 2894\u2013900.","DOI":"10.1093\/humrep\/del068"},{"key":"2022061700271503200_B27","doi-asserted-by":"crossref","unstructured":"Jagadish N, Rana R, Mishra D, Garg M, Selvi R, Suri A. Characterization of immune response in mice to plasmid DNA encoding human sperm associated antigen 9 (SPAG9). Vaccine\u20082006; 24: 3695\u2013703.","DOI":"10.1016\/j.vaccine.2005.07.007"},{"key":"2022061700271503200_B28","doi-asserted-by":"crossref","unstructured":"Tureci O, Sahin U, Zwick C, Koslowski M, Seitz G, Pfreundschuh M. Identification of meiosis-specific protein as a member of the class of cancer\/ testis antigens. Proc Natl Acad Sci U S A\u20081998; 95: 5211\u20136.","DOI":"10.1073\/pnas.95.9.5211"},{"key":"2022061700271503200_B29","doi-asserted-by":"crossref","unstructured":"Davis RJ. Signal transduction by the JNK group of MAP kinases. Cell\u20082000; 103: 239\u201352.","DOI":"10.1016\/S0092-8674(00)00116-1"},{"key":"2022061700271503200_B30","doi-asserted-by":"crossref","unstructured":"Haefliger JA, Tawadros T, Meylan L, et al. The scaffold protein IB1\/JIP-1 is a critical mediator of cytokine-induced apoptosis in pancreatic \u03b2 cells. J Cell Sci\u20082003; 116: 1463\u20139.","DOI":"10.1242\/jcs.00356"},{"key":"2022061700271503200_B31","doi-asserted-by":"crossref","unstructured":"Willoughby EA, Collins MK. Dynamic interaction between the dual specificity phosphatase MKP7 and the JNK3 scaffold protein \u03b2-arrestin 2. J Biol Chem\u20082005; 280: 25651\u20138.","DOI":"10.1074\/jbc.M501926200"},{"key":"2022061700271503200_B32","doi-asserted-by":"crossref","unstructured":"Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet\u20082000; 16: 168\u201374.","DOI":"10.1016\/S0168-9525(99)01971-X"},{"key":"2022061700271503200_B33","doi-asserted-by":"crossref","unstructured":"Wischnewski F, Pantel K, Schwarzenbach H. Promoter demethylation and histone acetylation mediate gene expression of MAGE-A1, -A2, -A3, and -A12 in human cancer cells. Mol Cancer Res\u20082006; 4: 339\u201349.","DOI":"10.1158\/1541-7786.MCR-05-0229"},{"key":"2022061700271503200_B34","doi-asserted-by":"crossref","unstructured":"Soussi T, Dehouche K, Beroud C. p53 website and analysis of p53 gene mutations in human cancer: forging a link between epidemiology and carcinogenesis. Hum Mutat\u20082000; 15: 105\u201313.","DOI":"10.1002\/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G"},{"key":"2022061700271503200_B35","doi-asserted-by":"crossref","unstructured":"Gurova KV, Hill JE, Razorenova OV, Chumakov PM, Gudkov AV. p53 pathway in renal cell carcinoma is repressed by a dominant mechanism. Cancer Res\u20082004; 64: 1951\u20138.","DOI":"10.1158\/0008-5472.CAN-03-1541"},{"key":"2022061700271503200_B36","doi-asserted-by":"crossref","unstructured":"Zigeuner R, Ratschek M, Rehak P, Schips L, Langner C. Value of p53 as a prognostic marker in histologic subtypes of RCC: a systemic analysis of primary and metastatic tumor tissue. Urology\u20082004; 63: 651\u20135.","DOI":"10.1016\/j.urology.2003.11.011"},{"key":"2022061700271503200_B37","doi-asserted-by":"crossref","unstructured":"Wei CL,Wu Q, Vega SV, et al. A global map of p53 transcription-factor binding sites in the human genome. Cell\u20082006; 124: 207\u201319.","DOI":"10.1016\/j.cell.2005.10.043"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/20\/8240\/2597831\/8240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/68\/20\/8240\/2597831\/8240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T00:48:14Z","timestamp":1655426894000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/68\/20\/8240\/541693\/Sperm-Associated-Antigen-9-Is-Associated-With"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,15]]},"references-count":37,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2008,10,15]]},"published-print":{"date-parts":[[2008,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-1708","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.22377255.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498498","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22377255","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6498498.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,15]]}}}